Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
Survivin (25–305)
AviHis加载中…
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| Survivin | SURVIVIN-HP004 | Human | HEK293 | Human HLA-A*02:01&B2M&Survivin (LTLGEFLKL) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | Survivin (25–305) AviHis |
| MAGE-A3 | MAGEA3-HP003 | Human | HEK293 | Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A3 (25–305) AviHis |
| HLA-A*03:01 | HLAA0301-HP002 | Human | E.coli | Human HLA-A*03:01&B2M&Influenza NP (ILRGSVAHK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 100 μg | HLA-A*03:01 (25–305) AviHis |
| AFP | AFP-HP004 | Human | HEK293 | Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | AFP (25–305) AviHis |
| LILRB4 | LILRB4-HP002 | Human | HEK293 | Non-biotinylated Human LILRB4/CD85k/ILT3 Domain 1+hinge Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB4 (22–123) AviHis |
| GP100 | GP100-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | GP100 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP004 | Human | E.coli | Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| KRAS G12V | KRASG12V-HB009 | Human | E.coli | Biotinylated Human HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| TdT | TDT-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&TdT (ALYDKTKRIFL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | TdT (25–305) AviHis |
| MAGE-A1 | MAGEA1-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A1 (25–305) AviHis |
| TdT | TDT-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&TdT (ALYDKTKRIFL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | TdT (25–305) AviHis |
| CD4 | CD4-HP003 | Human | HEK293 | Human CD4/LEU3 Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | CD4 (26–390) Fc |
| HBV | HBV-HB003 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HBV (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP012 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &mB2M&NY-ESO-1 (SLLMWITQC) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–206) His |
| HBV | HBV-HB002 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HBV (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB005 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&PLK1 (AAPGAPAAA) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB001 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&RAB7B (KLIIVGAIGV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| PRAME | PRAME-HP004 | Human | E.coli | Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | PRAME (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP010 | Human | E.coli | NY-ESO-1 (25–305) AviHis | |
| AFP | AFP-HB002 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | AFP (25–305) AviHis |